CoChat
Sign Up
Cited by 15Vaccine Coverage and HesitancyEconomic and Environmental ValuationSARS-CoV-2 and COVID-19 Research

Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach

Open access
Ong, Ardvin Kester S., Prasetyo, Yogi Tri, Lagura, Fae Coleen, Ramos, Rochelle Nicole, Salazar, Jose Ma Luis, Sigua, Keenan Mark, Villas, Jomy Anne, Chuenyindee, Thanatorn +3 more·2022·Public Health in Practice
DOI 10.1016/j.puhip.2022.100300PMC PMC9293378
Open this paper in CoChat — free accountOpen PDF

Abstract

Objective: Vaccines are utilized to prevent the severity of illnesses like the COVID-19 virus. Currently, there are a lot of COVID-19 vaccines available in the market like Pfizer, Moderna, AstraZeneca, Johnson and Johnson, and Sinovac. This research aimed to analyze the preference on the existing vaccine attributes of COVID-19. Study design: Specifically, this study considered 7 attributes such as cost, brand, recommendations, efficacy, side effects, vaccine type, and dose. Methods: A conjoint analysis with orthogonal design was utilized and 865 respondents were participated. Results: The result showed that consumers considered brand as the highest attribute, specifically Pfizer and Moderna among other brands. Moreover, the efficacy of 90% and higher were the preferred vaccine with 1 in 100 patient side effects reported. It was seen that safety and effectiveness is the priority in choosing a COVID-19 vaccine. Interestingly, the knowledge and understanding of the COVID-19 vaccine was found to drive consumer's preference for the vaccines available. Conclusions: The findings of this study could be utilized by the government to increase the willingness to be vaccinated. Lastly, the result of this study would pave a way to promote herd immunity to help fight the COVID-19 pandemic worldwide.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.puhip.2022.100300

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. [1]Kaya F, Pirincci E. Determining the frequency of serious adverse reactions of inactive SARS-COV-2 vaccine. Work. 2021(Preprint):1-5. 34219684
  2. [3]Jesus T.S. Landry M.D. Jacobs K. A ‘new normal’following COVID-19 and the economic crisis: using systems thinking to identify challenges and opportunities in disability, telework, and rehabilitation Work Preprint 2020 1 10 32955472
  3. [5]Kumari A. Ranjan P. Chopra S. Kaur D. Upadhyay A.D. Kaur T. Development and validation of a questionnaire to assess knowledge, attitude, practices, and concerns regarding covid-19 vaccination among the general population Diabetes Metabol. Syndr.: Clin. Res. Rev. 15 3 2021 919 925 PMC8056878 33930855
  4. [6]Murphy J. Vallières F. Bentall R.P. Shevlin M. McBride O. Hartman T.K. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom Nat. Commun. 12 1 2021 1 15 33397962 PMC7782692
  5. [7]Chu H. Liu S. Integrating Health Behavior Theories to Predict American's Intention to Receive a COVID-19 Vaccine 2021 Patient Education and Counseling PMC7889032 33632632
  6. [11]Yousefinaghani S. Dara R. Mubareka S. Papadopoulos A. Sharif S. An analysis of COVID-19 vaccine sentiments and opinions on twitter Int. J. Infect. Dis. 108 2021 256 262 10.1016/j.ijid.2021.05.059 34052407 PMC8157498 · DOI
  7. [14]Shen M. Zu J. Fairley C.K. Pagán J.A. An L. Du Z. Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use Vaccine 39 16 2021 2295 2302 33771391 PMC7914016
  8. [15]Motta M. Can a COVID-19 vaccine live up to Americans' expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions Soc. Sci. Med. 272 2021 113642 PMC7832269 33414031
  9. [16]Wong M.C. Wong E.L. Huang J. Cheung A.W. Law K. Chong M.K. Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong Vaccine 39 7 2021 1148 1156 33461834 PMC7832076
  10. [17]McKee C. Bohannon K. Exploring the reasons behind parental refusal of vaccines J. Pediatr. Pharmacol. Therapeut. 21 2 2016 104 109 PMC4869767 27199617
  11. [18]Xiao X. Wong R.M. Vaccine hesitancy and perceived behavioral control: a meta-analysis Vaccine 38 33 2020 5131 5138 32409135
  12. [19]Stockwell M.S. Rosenthal S.L. Sturm L.A. Mays R.M. Bair R.M. Zimet G.D. The effects of vaccine characteristics on adult women's attitudes about vaccination: a conjoint analysis study Vaccine 29 27 2011 4507 4511 21527303 PMC3119026
  13. [20]Sun X. Wagner A.L. Ji J. Huang Z. Zikmund-Fisher B.J. Boulton M.L. A conjoint analysis of stated vaccine preferences in Shanghai, China Vaccine 38 6 2020 1520 1525 31822426
  14. [21]Seanehia J. Treibich C. Holmberg C. Müller-Nordhorn J. Casin V. Raude J. Quantifying population preferences around vaccination against severe but rare diseases: a conjoint analysis among French university students Vaccine 35 20 2016 2676 2684 2017 28408120
  15. [24]Omar D.I. Hani B.M. Attitudes and intentions towards COVID-19 vaccines and associated factors among Egyptian adults Journal of Infection and Public Health 14 10 2021 1481 1488 34247946 PMC8253692
  16. [25]Stevens E.B. Jason L.A. Evaluating alcoholics anonymous sponsor attributes using conjoint analysis Addict. Behav. 51 2015 12 17 26186375 PMC4558395
  17. [26]Macindo J.R.B. Danganan M.P.B. Soriano C.A.F. Kho N.S.R. Bongar M.V.V. A conjoint analysis of the acute and critical care experiential learning preferences of Baccalaureate student nurses Nurse Educ. Pract. 36 2019 125 131 30925283
  18. [28]Ong A.K.S. Prasetyo Y.T. Libiran M. Lontoc Y.M.A. Lunaria J.A.V. Manalo A.M. Consumer preference analysis on attributes of milk tea: a conjoint analysis approach Foods 10 6 2021 1382 34203864 PMC8232735
  19. [30]García-Torres S. López-Gajardo A. Mesías F. Intensive vs. free-range organic beef. A preference study through consumer liking and conjoint analysis Meat Sci. 114 2016 114 120 26771143
  20. [32]Landfeldt E. Eriksson J. Ireland S. Musingarimi P. Jackson C. Tweats E. Patient, physician, and general population preferences for treatment characteristics in relapsed or refractory chronic lymphocytic leukemia: a conjoint analysis Leuk. Res. 40 2016 17 23 26654707
  21. [33]Manjunath R. Yang J.-C. Ettinger A.B. Patients' preferences for treatment outcomes of add- on antiepileptic drugs: a conjoint analysis Epilepsy Behav. 24 4 2012 474 479 22770879
  22. [34]Shammas R.L. Mela N. Wallace S. Tong B.C. Huber J. Mithani S.K. Conjoint analysis of treatment preferences for nondisplaced scaphoid fractures J. Hand Surg. 43 7 2018 678 e1-. e9 29456053
  23. [35]Johansson G. Sta B. Tornling G. Andersson S. Karlsson G.S. Fa K. Asthma treatment preference study: a conjoint analysis of preferred drug treatments Chest 125 3 2004 916 923 15006950
  24. [36]Beusterien K.M. Dziekan K. Flood E. Harding G. Jordan J.C. Understanding patient preferences for HIV medications using adaptive conjoint analysis: feasibility assessment Value Health 8 4 2005 453 461 16091022
  25. [40]Kreps S. Kriner D. Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: evidence from a conjoint experiment Vaccine 39 24 2021 3250 3258 10.1016/j.vaccine.2021.04.044 33966909 PMC8064867 · DOI
  26. [41]Zandian H, Sarailoo M, Dargahi S, Gholizadeh H, Vosoughi M, Dargahi A. Evaluation of knowledge and health behavior of university of medical sciences students about the prevention of COVID-19. Work. 2021(Preprint):1-7. 33612505
  27. [42]Connochie D. Tingler R.C. Bauermeister J.A. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: results from a nationwide online pilot study Vaccine 37 43 2019 6494 6499 31522806 PMC6764873
  28. [43]Riad A. Pokorná A. Attia S. Klugarová J. Koščík M. Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech republic J. Clin. Med. 10 7 2021 1428 33916020 PMC8037149
  29. [44]Waters E.A. Pachur T. Colditz G.A. Side effect perceptions and their impact on treatment decisions in women Med. Decis. Making 37 3 2017 193 203 27216581 PMC5121093
  30. [45]Baldolli A. Michon J. Verdon R. Fournier A. Vaccination perception and coverage among healthcare students in France in 2019 BMC Med. Educ. 20 1 2020 1 10 PMC7734903 33317501
  31. [49]Baraniuk C. Covid-19: what Do We Know about Sputnik V and Other Russian Vaccines? Bmj 2021 372 33741559
  32. [51]CfDCa Prevention Different COVID-19 Vaccines 2021 Centers for Disease Control and Prevention [Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html 34009769
  33. [56]Consumer preference analysis on flute attributes in Indonesia using conjoint analysis ICADRE14 Prasetyo Y.T. Suzianti A. Dewi A.P. Proceedings of the International Conference on Advanced Design Research and Education 2014
  34. [63]Tkatek S. Belmzoukia A. Nafai S. Abouchabaka J. Ibnou-Ratib Y. Putting the world back to work: an expert system using big data and artificial intelligence in combating the spread of COVID-19 and similar contagious diseases Work Preprint 2020 1 16 33164971
  35. [66]Ong Ardvin Kester S. Tri Prasetyo Yogi Chuenyindee Thanatorn Young Michael Nayat Doma Bonifacio T. Caballes Dennis G. Centeno Raffy S. Morfe Anthony S. Bautista Christine S. Preference analysis on the online learning attributes among senior high School students during the COVID-19 pandemic: a conjoint analysis approach Eval. Progr. Plann. 92 2022 102100 PMC9023093 35487051
  36. [67]Al Naam Y.A. Elsafi S.H. Alkharraz Z.S. Almaqati T.N. Alomar A.M. Al Balawi I.A. Factors related to COVID-19 vaccine hesitancy in Saudi Arabia Pub. Health Pract. 3 2022 100258 PMC9023360 35479261
  37. [68]Gbeasor-Komlanvi F.A. Afanvi K.A. Konu Y.R. Agbobli Y. Sadio A.J. Tchankoni M.K. Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 2021 Pub. Health Pract. 2 2021 100220 PMC8612761 34849496

Cited by

Sorted by citations

Authors
Ong, A. K. S., Prasetyo, Y. T., Lagura, F. C., Ramos, R. N., Salazar, J. M. L., Sigua, K. M., Villas, J. A., Chuenyindee, T., Nadlifatin, R., Persada, S. F., & Thana, K.
Affiliations
  • Mapúa University (PH)
  • Institut Teknologi Sepuluh Nopember (ID)
  • Binus University (ID)
  • Navaminda Kasatriyadhiraj Royal Thai Air Force Academy (TH)
Corresponding author
Prasetyo, Yogi Tri
ORCID
Venue
Public Health in Practice
Publisher
Elsevier BV
Published
2022-12
Volume
4
Pages
100300
ISSN
2666-5352 (ISSN-L)
DOI
10.1016/j.puhip.2022.100300
PMC
PMC9293378
OpenAlex
W4285807879
Cited by
15
References
2
Citations by year
2026: 1 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 1
FWCI
2.69
Type
journal article
Language
en
Open access
Licence
Locations
  • Public Health in Practice (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 vaccines, vaccine preferences, young adults, vaccine attributes, vaccine efficacy, vaccine side effects, vaccine cost, vaccine knowledge, vaccine willingness, herd immunity, Pfizer, Moderna, AstraZeneca, Johnson & Johnson, Sinovac, Philippines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review